PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2013 | 8 | 5 | 558-564
Article title

Anti-granulocyte scintigraphy in early rheumatoid arthritis - does it work?

Content
Title variants
Languages of publication
EN
Abstracts
EN
Publisher

Journal
Year
Volume
8
Issue
5
Pages
558-564
Physical description
Dates
published
1 - 10 - 2013
online
18 - 9 - 2013
Contributors
author
  • Department of Radiology, University of Debrecen, Medical & Health Sciences Centre, H-4032, Debrecen, Nagyerdei krt. 98., Hungary
  • Department of Rheumatology, ’Kenézy Gyula’ Hospital, H-4043, Debrecen, Bartók Béla u. 2-26., Hungary
author
  • Department of Nuclear Medicine, University of Debrecen, Medical & Health Sciences Centre, H-4032, Debrecen, Nagyerdei krt. 98, Hungary
  • Medical & Health Sciences Centre, PET-CT Medical Diagnostics Ltd., University of Debrecen, H-4032, Debrecen, Nagyerdei krt. 98, Hungary
author
  • Medical & Health Sciences Centre, PET-CT Medical Diagnostics Ltd., University of Debrecen, H-4032, Debrecen, Nagyerdei krt. 98, Hungary
author
  • Department of Rheumatology, ’Kenézy Gyula’ Hospital, H-4043, Debrecen, Bartók Béla u. 2-26., Hungary, gaalja@freemail.hu
References
  • [1] Kellgren J.H., O’Brien W.M. On the natural history of rheumatoid arthritis in relation to the sheep cell agglutination test (SCAT), Arthritis. Rheum., 1962, 5, 115
  • [2] Withrington R.H., Teitsson I., Valdimarsson H., Seifert M.H. Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity, Ann. Rheum. Dis., 1984, 43(5), 679–685 http://dx.doi.org/10.1136/ard.43.5.679[Crossref]
  • [3] Sharp J.T., Calkins E., Cohen A.S., Schubart A.F., Calabro J.J. Observations on the clinical, chemical, and serological manifestations of rheumatoid arthritis, based on the course of 154 cases, Medicine (Baltimore), 1964, 43, 41–58
  • [4] Geborek P., Saxne T., Pettersson H., Wollheim F.A. Syno.vial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints, J. Rheumatol., 1989, 16(4), 468–472
  • [5] Tseng S., Reddi A.H., Di Cesare P.E. Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis, Biomark. Insights. 2009, 17(4), 33–44
  • [6] Fujikawa K., Kawakami A., Tamai M., Uetani M., Takao S., Arima K., et al., High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion, J. Rheumatol., 2009, 36(6), 1126–1129 http://dx.doi.org/10.3899/jrheum.080926[WoS]
  • [7] Syversen S.W., Goll G.L., van der Heijde D., Landewé R., Gaarder P.I., Odegård S., et al., Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression, J. Rheumatol. 2009, 36(2), 266–272 http://dx.doi.org/10.3899/jrheum.080180
  • [8] Rousseau J.C., Sumer E.U., Hein G., Sondergaard B.C., Madsen S.H., Pedersen C., et al., Patients with rheumatoid arthritis have an altered circulatory aggrecan profile, BMC Musculoskelet. Disord., 2008, 28,9:74 http://dx.doi.org/10.1186/1471-2474-9-74[Crossref]
  • [9] Syversen S.W., Goll G.L., van der Heijde D., Landewé R., Lie B.A., Odegard, S., et al., Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a ten-year prospective study, Ann. Rheum. Dis., 2010. 69(2), 345–351 http://dx.doi.org/10.1136/ard.2009.113092[Crossref]
  • [10] Firestein G.S., Etiology and pathogenesis of rheumatoid arthritis, In: Kelly’s Texbook of Rherumatology (Harris E.D.Jr, Budd R.C., Genovese M.C., Firestein G.S., Sargent J.S., Sledge B.C. eds) 7th ed. Oxford 2004, 996–1042
  • [11] Gaál J., Mézes A., Síró B., Varga J., Galuska L., Jánoky G., et al., Tc99m HMPAO labeled leukocyte scintigraphy in patients with rheumatoid arthritis: a comparison with disease activity, Nucl. Med. Commun., 2002, 23:39–46 http://dx.doi.org/10.1097/00006231-200201000-00007[Crossref]
  • [12] Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis. Rheum., 1988, 31,:315–324 http://dx.doi.org/10.1002/art.1780310302
  • [13] Klarlund M., Ostergaard M., Jensen K.E., Madsen J.L., Skjødt H., Lorenzen I., et al., Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group, Ann. Rheum. Dis. 2000, 59(7), 521–528 http://dx.doi.org/10.1136/ard.59.7.521[Crossref]
  • [14] Fransen J., van Riel P.L., The Disease Activity Score and the EULAR response criteria, Rheum. Dis. Clin. North. Am., 2009, 35(4), 745–757 http://dx.doi.org/10.1016/j.rdc.2009.10.001[Crossref][WoS]
  • [15] Hetland M.L., Ejbjerg B., Hørslev-Petersen K., Jacobsen S., Vestergaard A., Jurik A.G., et al. CIMESTRA study group., MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA), Ann. Rheum. Dis., 2009, 68(3), 384–390 http://dx.doi.org/10.1136/ard.2008.088245
  • [16] Palosaari K., Vuotila J., Takalo R., Jartti A., Niemelä R.K., Karjalainen A., et al. Bone oedema predicts erosive progression on wrist MRI in early RA-a 2-yr observational MRI and NC scintigraphy study, Rheumatology, 2006, 45(12), 1542–1548 http://dx.doi.org/10.1093/rheumatology/kel137
  • [17] Ostendorf B., Schneider M., [Imaging beyond conventional radiography: mini arthroscopy, duplex ultrasonography and positron emission tomography] Z. Rheumatol., 2003, 62(Suppl 2), II 37–40
  • [18] van der Laken C.J., Elzinga E.H., Kropholler M.A., Molthoff C.F., van der Heijden J.W., Maruyama K., et al., Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography, Arthritis. Rheum., 2008, 58(11), 3350–3355 http://dx.doi.org/10.1002/art.23955[Crossref]
  • [19] Möttönen T.T., Hannonen P., Toivanan J., Rekonen A., Oka M. M., Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis, Ann. Rheum. Dis., 1988, 47, 183–189 http://dx.doi.org/10.1136/ard.47.3.183[Crossref]
  • [20] de Bois M.H., Westedt M.L., Arndt J.W., Wiarda K.S., van der Velde E.A., Pauwels EK., et al., Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset, Rheumatol. Int., 1995, 15(4), 155–158 http://dx.doi.org/10.1007/BF00301773[Crossref]
  • [21] Takalo R., Niemelä R., Karjalainen A., Leisti E.L., Kautiainen H., Hakala M., (99m)Technetium nanocolloid scintigraphy in prognostication of early RA Scand. J. Rheumatol. 2011, 40(2), 152–153
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11536-013-0203-4
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.